6CM

683 Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Hold	0	–	–	–	120
2025 Q1	–	Hold	0	–	–	–	122
2024 Q4	–	Hold	0	–	–	–	211
2024 Q3	–	Hold	0	–	–	–	130
2024 Q2	–	Hold	0	–	–	–	133
2024 Q1	–	Hold	0	–	–	–	128
2023 Q4	–	Hold	0	–	–	–	242
2023 Q3	–	Hold	0	–	–	–	137
2022 Q3	–	Sell	-39,000	Closed	-$5.69M	–	236
2022 Q2	$5.69M	Sell	39,000 -10,000	-20%	-$1.46M	0.4%	66
2022 Q1	$8M	Hold	49,000	–	–	0.43%	56
2021 Q4	$8.31M	Hold	49,000	–	–	0.31%	64
2021 Q3	$9.25M	Sell	49,000 -6,000	-11%	-$1.13M	0.36%	59
2021 Q2	$9.32M	Hold	55,000	–	–	0.32%	58
2021 Q1	$7.77M	Sell	55,000 -50,000	-48%	-$7.06M	0.41%	51
2020 Q4	$13.6M	Hold	105,000	–	–	0.65%	32
2020 Q3	$15.3M	Hold	105,000	–	–	1.12%	17
2020 Q2	$15.6M	Sell	105,000 -65,000	-38%	-$9.63M	1.24%	15
2020 Q1	$18.5M	Sell	170,000 -55,000	-24%	-$5.99M	2.17%	11
2019 Q4	$25.9M	Sell	225,000 -129,000	-36%	-$14.9M	2.96%	5
2019 Q3	$28.5M	Buy	354,000 +14,000	+4%	+$1.13M	3.17%	2
2019 Q2	$24.7M	Buy	340,000 +14,000	+4%	+$1.02M	2.24%	5
2019 Q1	$30.5M	Hold	326,000	–	–	2.76%	5
2018 Q4	$23.8M	Buy	326,000 +26,000	+9%	+$1.9M	1.44%	6
2018 Q3	$26.3M	Hold	300,000	–	–	1.7%	8
2018 Q2	$29.5M	Buy	300,000 +110,000	+58%	+$10.8M	2%	6
2018 Q1	$22.6M	Sell	190,000 -10,000	-5%	-$1.19M	2%	8
2017 Q4	$25.4M	Sell	200,000 -39,500	-16%	-$5.02M	2.14%	3
2017 Q3	$28.1M	Sell	239,500 -30,500	-11%	-$3.58M	2.96%	3
2017 Q2	$21.5M	Hold	270,000	–	–	3.17%	3
2017 Q1	$13.8M	Hold	270,000	–	–	2.15%	10
2016 Q4	$10.1M	Buy	270,000 +150,000	+125%	+$5.62M	0.72%	15
2016 Q3	$8.13M	Buy	+120,000	New	+$8.13M	0.86%	15